Role of proteinase-activated receptors 1 and 2 in nonsteroidal anti-inflammatory drug enteropathy.
Matteo FornaiRocchina ColucciCarolina PellegriniLaura BenvenutiGianfranco NataleLarisa RyskalinCorrado BlandizziLuca AntonioliPublished in: Pharmacological reports : PR (2020)
PAR2 is involved in the pathogenesis of indomethacin enteropathy, through pro-inflammatory mechanisms and an impairment of the intestinal epithelial barrier. PAR1 activation and PAR2 inhibition could represent suitable strategies for the prevention of NSAID enteropathy.